The global Cell & Gene Therapy Manufacturing Services Market was valued at USD 11.4 billion in 2023 and is projected to reach USD 70.7 billion by 2032, growing at a compound annual growth rate (CAGR) of 22.4% over the forecast period from 2024 to 2032. The rising demand for cell and gene therapies, coupled with the increasing trend of outsourcing...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian